11268388|t|Interleukin-1 beta and thymic peptide regulation of pituitary and glial cell cytokine expression and cellular proliferation.
11268388|a|Interleukin-6 (IL-6) is a B-cell differentiating and T-cell activating cytokine that is expressed in T cells, neutrophils, monocytes, macrophages, and mast cells. Because IL-6 is also synthesized and released by anterior pituitary cells and IL-6 stimulates pituitary hormone release, this cytokine may serve a paracrine or autocrine role within the pituitary. Interleukin-1 beta (IL-1 beta) stimulates IL-6 release from anterior pituitary cells through a mechanism that involves lysophosphatidylcholine (LPC 18:0) generation and protein kinase C activation. In the rat C6 glioma cell line, IL-1 beta synergistically stimulates IL-6 release in the presence of increased intracellular cAMP concentrations. The catecholamines and serotonin also synergistically stimulate IL-6 release in the presence of IL-1 beta. LPC 18:0 synergistically increases IL-6 release in the presence of norepinephrine, and IL-1 beta transiently increases LPC 18:0 formation in C6 cells. Therefore, IL-1 beta induction of LPC 18:0 may lead to increases in IL-6 production via activation of a kinase cascade. The bovine thymic preparation, thymosin fraction 5 (TF5), also stimulates IL-6 release from C6 glioma cells in a protein kinase C-dependent manner. Of interest, TF5 inhibits the proliferation of C6 cells, pituitary adenoma MMQ cells, and promyelocytic HL-60 cells. We suggest that a thymic hormone immune surveillance mechanism may suppress neuroendocrine and hematopoietic tumor formation. Thus, IL-1 beta and certain thymic peptides act to increase IL-6 expression in neuroendocrine cells. The enhanced production of neuroendocrine cytokines may affect hormone secretion, neurotransmission, and the development of certain neurodegenerative disorders (e.g., Alzheimer's disease). The isolation of the active component of TF5 that inhibits neuroendocrine and hematopoietic tumor cell proliferation will provide a potential therapeutic strategy for the treatment of these tumors.
11268388	0	18	Interleukin-1 beta	Gene	24494
11268388	125	138	Interleukin-6	Gene	24498
11268388	140	144	IL-6	Gene	24498
11268388	296	300	IL-6	Gene	24498
11268388	366	370	IL-6	Gene	24498
11268388	485	503	Interleukin-1 beta	Gene	24494
11268388	505	514	IL-1 beta	Gene	24494
11268388	527	531	IL-6	Gene	24498
11268388	604	627	lysophosphatidylcholine	Chemical	MESH:D008244
11268388	629	632	LPC	Chemical	-
11268388	690	693	rat	Species	10116
11268388	694	703	C6 glioma	CellLine	CVCL:3581
11268388	715	724	IL-1 beta	Gene	24494
11268388	752	756	IL-6	Gene	24498
11268388	808	812	cAMP	Chemical	-
11268388	833	847	catecholamines	Chemical	MESH:D002395
11268388	852	861	serotonin	Chemical	MESH:D012701
11268388	893	897	IL-6	Gene	24498
11268388	925	934	IL-1 beta	Gene	24494
11268388	971	975	IL-6	Gene	24498
11268388	1003	1017	norepinephrine	Chemical	MESH:D009638
11268388	1023	1032	IL-1 beta	Gene	24494
11268388	1055	1058	LPC	Chemical	-
11268388	1077	1079	C6	CellLine	CVCL:0194
11268388	1098	1107	IL-1 beta	Gene	24494
11268388	1155	1159	IL-6	Gene	24498
11268388	1211	1217	bovine	Species	9913
11268388	1281	1285	IL-6	Gene	24498
11268388	1299	1308	C6 glioma	CellLine	CVCL:3581
11268388	1402	1404	C6	CellLine	CVCL:0194
11268388	1412	1429	pituitary adenoma	Disease	MESH:D010911
11268388	1430	1433	MMQ	CellLine	CVCL:2117
11268388	1459	1464	HL-60	CellLine	CVCL:0002
11268388	1548	1586	neuroendocrine and hematopoietic tumor	Disease	MESH:D018358
11268388	1604	1613	IL-1 beta	Gene	24494
11268388	1658	1662	IL-6	Gene	24498
11268388	1677	1691	neuroendocrine	Disease	MESH:D018358
11268388	1726	1740	neuroendocrine	Disease	MESH:D018358
11268388	1831	1858	neurodegenerative disorders	Disease	MESH:D019636
11268388	1866	1885	Alzheimer's disease	Disease	MESH:D000544
11268388	1947	1985	neuroendocrine and hematopoietic tumor	Disease	MESH:D018358
11268388	2078	2084	tumors	Disease	MESH:D009369
11268388	Association	MESH:D012701	24494
11268388	Association	MESH:D019636	24494
11268388	Association	MESH:D018358	24494
11268388	Positive_Correlation	MESH:D002395	24498
11268388	Association	MESH:D008244	24494
11268388	Association	MESH:D002395	24494
11268388	Association	MESH:D000544	24498
11268388	Positive_Correlation	MESH:D008244	24498
11268388	Positive_Correlation	MESH:D012701	24498
11268388	Association	MESH:D000544	24494
11268388	Positive_Correlation	24494	24498

